ELNA Medical Group Inc. and certain of its subsidiaries in its court-approved Sale and Investment Solicitation Process (SISP) under the Companies’ Creditors Arrangement Act ELNA Medical Group Inc. and certain of its subsidiaries in its court-approved Sale and Investment Solicitation Process (SISP) under the Companies’ Creditors Arrangement Act

In December 2024, ELNA Medical Group Inc. and certain of its subsidiaries obtained creditor protection, initiated proceedings and launched a court-approved Sale and Investment Solicitation Process (SISP) under the Companies’ Creditors Arrangement Act. As part of the SISP, ELNA Medical Group Inc. sold its subsidiary Medicentres Canada Inc. to Medavie Inc. on April 30, 2025, the assets of its subsidiary Clinique Privamed Inc. to 17009321 Canada Inc. (a Paraide International Healthcare company) effective June 10, 2025, and the assets of its subsidiary m-Health Solutions Inc. to CML HealthCare Inc. on June 16, 2025.

ELNA Medical is a network of clinics and entities with various primary and specialty medical services, therapies, procedures and diagnostic services.

Osler, Hoskin & Harcourt LLP advised ELNA Medical Group Inc. and certain of its subsidiaries on the transactions with a team consisting of Sandra Abitan, Julien Morissette, Ilia Kravtsov, Jack Little (Insolvency and Restructuring), Matthew Oliver and Samuel Cantin (Corporate), Alain Fournier and Geneviève Beebe (Tax), Susan Newell and Lauren Hebert (Health), François Joli-Coeur and Catherine Labasi-Sammartino (Privacy).